Advertisement

Topics

Mersana Nabs $6M Debt Deal

09:38 EDT 22 Apr 2011 |

[[Corrected 4/22/11 at 2:15 pm]]Mersana Therapeutics, a Cambridge, MA-based drug maker, has brought in $6 million of a targeted $10 million debt offering, from seven investors, according to an SEC filing. Last year, the company inked a deal that could be worth $334 million with Israel-based Teva Pharmaceutical Industries, for developing a new polymer-based drug [...]

Original Article: Mersana Nabs $6M Debt Deal

NEXT ARTICLE

More From BioPortfolio on "Mersana Nabs $6M Debt Deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...